The Alliance’s blog offers a personal, inside look at our activities and perspectives on a range of timely issues. We encourage your feedback.


Author: Noel Lloyd

Date: March 29th, 2016

On April 7, the Alliance's Vice President of Public Policy Cynthia Bens will participate in a symposium titled "Frailty as a Baseline Stratification Parameter and Potential Therapeutic Target" at the 28th Annual EuroMeeting in Hamburg, Germany.

This session will look at the progress that has been made in drug development for and with older adults.  It "will announce and discuss the brand new EMA Geriatric Working Party frailty definition selected for study baseline characteristics for clinical studies and propose how this will change the research landscape in geriatric studies in Europe and beyond." 

During the session, Bens will address areas of need and insufficient research in the frailty arena. She joins the following experts: Susan Morgan, Medicines & Healthcare Products Regulatory Agency (MHRA), United Kingdom; Susanna Del Signore, M.D., Bluecompanion, United Kingdom; Antonio Cherubini, IRCCS-INRCA, Italy; and Francesca Cerreta, European Medicines Agency, European Union.

To find out more, go to the session information page. 



A Tribute to a Great Scientist

Author: Dan Perry

Date: March 11th, 2008

FDA Needs More Funding to Fulfill Its Mission

Author: Cynthia Bens

Date: March 18th, 2008

Spending or Investing? -- The Silver Book & Innovation

Author: Lindsay Clarke

Date: March 26th, 2008

A Q & A with Prof. Pieter Kappetein from Medtronic

Author: Alliance Staff

Date: February 20th, 2018

The Tax Cuts and Jobs Act: What Does It Mean for Older Adults?

Author: Noel Lloyd

Date: January 19th, 2018

HROTW: Learn about Age-Related Macular Degeneration in 60 Seconds

Author: Breanna Bishop

Date: December 20th, 2017

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It